118 related articles for article (PubMed ID: 35493778)
1. High-resolution disease maps for cancer control in low-resource settings: A spatial analysis of cervical cancer incidence in Kampala, Uganda.
Beyer K; Kasasa S; Anguzu R; Lukande R; Nambooze S; Amulen PM; Zhou Y; Nansereko B; Jankowski C; Oyana T; Savino D; Feustel K; Wabinga H
J Glob Health; 2022; 12():04032. PubMed ID: 35493778
[TBL] [Abstract][Full Text] [Related]
2. Infection-related and lifestyle-related cancer burden in Kampala, Uganda: projection of the future cancer incidence up to 2030.
Asasira J; Lee S; Tran TXM; Mpamani C; Wabinga H; Jung SY; Chang YJ; Park Y; Cho H
BMJ Open; 2022 Mar; 12(3):e056722. PubMed ID: 35296484
[TBL] [Abstract][Full Text] [Related]
3. U.S. geographic distribution of prevaccine era cervical cancer screening, incidence, stage, and mortality.
Horner MJ; Altekruse SF; Zou Z; Wideroff L; Katki HA; Stinchcomb DG
Cancer Epidemiol Biomarkers Prev; 2011 Apr; 20(4):591-9. PubMed ID: 21266522
[TBL] [Abstract][Full Text] [Related]
4. Cancer in Kampala, Uganda, in 1989-91: changes in incidence in the era of AIDS.
Wabinga HR; Parkin DM; Wabwire-Mangen F; Mugerwa JW
Int J Cancer; 1993 Apr; 54(1):26-36. PubMed ID: 8478145
[TBL] [Abstract][Full Text] [Related]
5. Resource requirements for cancer registration in areas with limited resources: Analysis of cost data from four low- and middle-income countries.
Tangka FK; Subramanian S; Edwards P; Cole-Beebe M; Parkin DM; Bray F; Joseph R; Mery L; Saraiya M;
Cancer Epidemiol; 2016 Dec; 45 Suppl 1(Suppl 1):S50-S58. PubMed ID: 27793574
[TBL] [Abstract][Full Text] [Related]
6. Optimal human papillomavirus vaccination strategies to prevent cervical cancer in low-income and middle-income countries in the context of limited resources: a mathematical modelling analysis.
Drolet M; Laprise JF; Martin D; Jit M; Bénard É; Gingras G; Boily MC; Alary M; Baussano I; Hutubessy R; Brisson M
Lancet Infect Dis; 2021 Nov; 21(11):1598-1610. PubMed ID: 34245682
[TBL] [Abstract][Full Text] [Related]
7. Knowledge, attitudes, and practice of cervical cancer prevention among health workers in rural health centres of Northern Uganda.
Obol JH; Lin S; Obwolo MJ; Harrison R; Richmond R
BMC Cancer; 2021 Feb; 21(1):110. PubMed ID: 33535977
[TBL] [Abstract][Full Text] [Related]
8. Estimating cancer incidence in Uganda: a feasibility study for periodic cancer surveillance research in resource limited settings.
Nakaganda A; Spencer A; Orem J; Mpamani C; Wabinga H; Nambooze S; Kiwanuka GN; Atwine R; Gemmell I; Jones A; Verma A
BMC Cancer; 2023 Aug; 23(1):772. PubMed ID: 37596529
[TBL] [Abstract][Full Text] [Related]
9. Perceptions of key informants on the provision of cervical cancer prevention and control programme in Uganda: implication for cervical cancer policy.
Obol JH; Harrison R; Lin S; Obwolo MJ; Richmond R
BMC Public Health; 2020 Sep; 20(1):1396. PubMed ID: 32928155
[TBL] [Abstract][Full Text] [Related]
10. The socioeconomic burden of a diagnosis of cervical cancer in women in rural Uganda: findings from a descriptive qualitative study.
Germans N; Ellis P; Wilson S; Merriman A; Rabwoni M
Int J Palliat Nurs; 2022 Jul; 28(7):322-332. PubMed ID: 35861442
[TBL] [Abstract][Full Text] [Related]
11. Spatiotemporal mapping of cervical cancer incidence highlights need for targeted prevention in Songkhla province, Thailand.
Zhao J; Virani S; Sriplung H
Health Policy Plan; 2017 Apr; 32(3):430-436. PubMed ID: 27935803
[TBL] [Abstract][Full Text] [Related]
12. Cervical Cancer in Sub-Saharan Africa: A Multinational Population-Based Cohort Study of Care and Guideline Adherence.
Griesel M; Seraphin TP; Mezger NCS; Hämmerl L; Feuchtner J; Joko-Fru WY; Sengayi-Muchengeti M; Liu B; Vuma S; Korir A; Chesumbai GC; Nambooze S; Lorenzoni CF; Akele-Akpo MT; Ayemou A; Traoré CB; Wondemagegnehu T; Wienke A; Thomssen C; Parkin DM; Jemal A; Kantelhardt EJ
Oncologist; 2021 May; 26(5):e807-e816. PubMed ID: 33565668
[TBL] [Abstract][Full Text] [Related]
13. Provision of cervical cancer prevention services in Northern Uganda: a survey of health workers from rural health centres.
Obol JH; Lin S; Obwolo MJ; Harrison R; Richmond R
BMC Health Serv Res; 2021 Aug; 21(1):794. PubMed ID: 34380470
[TBL] [Abstract][Full Text] [Related]
14. Model-based impact and cost-effectiveness of cervical cancer prevention in sub-Saharan Africa.
Kim JJ; Campos NG; O'Shea M; Diaz M; Mutyaba I
Vaccine; 2013 Dec; 31 Suppl 5():F60-72. PubMed ID: 24331749
[TBL] [Abstract][Full Text] [Related]
15. Cancer burden and control in the Western Pacific region: challenges and opportunities.
Varghese C; Carlos MC; Shin HR
Ann Glob Health; 2014; 80(5):358-69. PubMed ID: 25512151
[TBL] [Abstract][Full Text] [Related]
16. Integrated cervical cancer screening in Mayuge District Uganda (ASPIRE Mayuge): a pragmatic sequential cluster randomized trial protocol.
Nakisige C; Trawin J; Mitchell-Foster S; Payne BA; Rawat A; Mithani N; Amuge C; Pedersen H; Orem J; Smith L; Ogilvie G
BMC Public Health; 2020 Jan; 20(1):142. PubMed ID: 32005202
[TBL] [Abstract][Full Text] [Related]
17. Cervical cancer incidence in the United States by area of residence, 1998 2001.
Benard VB; Coughlin SS; Thompson T; Richardson LC
Obstet Gynecol; 2007 Sep; 110(3):681-6. PubMed ID: 17766618
[TBL] [Abstract][Full Text] [Related]
18. Grade of malignancy of cervical cancer in regions of Uganda with varying malarial endemicity.
Odida M; Schmauz R; Lwanga SK
Int J Cancer; 2002 Jun; 99(5):737-41. PubMed ID: 12115509
[TBL] [Abstract][Full Text] [Related]
19. Temporal changes in the cervical cancer burden in Bulgaria: Implications for eastern european countries going through transition.
Samson KK; Haynatzki G; Soliman AS; Valerianova Z
Cancer Epidemiol; 2016 Oct; 44():154-160. PubMed ID: 27597149
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
